Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent

Oncology Reports

Volumn 11, Issue 6, 2004, Pages 1193-1200

  Soliani, Paolo ^a   Ziegler, Stefanie ^a   Romani, Antonello ^a   Corcione, Luigi ^a   Campanini, Nicoletta ^a   Dell'Abate, Paolo ^a   Del Rio, Paolo ^a   Sianesi, Mario ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Colorectal cancer; Immunohistochemistry; nm23; Prognosis

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; COLORECTAL TUMOR; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 13844299981     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.6.1193     Document Type: Article

References (46)

1. SEER Cancer Statistics Review, 1973-1998. Surveillance, Epidemiology and End Results program, Division of Cancer Control and Population Sciences. National Cancer Institute, 2001.
2. Berney CR, Fisher R, Yang J, Russell P and Crowe PJ: Protein markers in colorectal cancer. Ann Surg 230: 179-184, 1999.
3. McLeod HL and Murray GI: Tumour markers of prognosis in colorectal cancer. Br J Cancer 79: 191-203, 1999. (Pubitemid 29002285)
4. Liotta LA, Stetler-Stevenson W and Steeg PS: Metastasis suppressor genes. Import Adv Oncol 123: 85-100, 1991.
5. Cawkwell L, Lewis FA and Quirke P: Frequency of allele loss of DCC, p53, RB1, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 70: 813-818, 1994. (Pubitemid 24331070)
6. Baker SJ, Fearon ER and Nigro JM: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217-221, 1989. (Pubitemid 19110302)
7. Kern SE, Fearon ER and Tersmette KWF: Allelic loss in colorectal carcinoma. JAMA 261: 3099-3103, 1989. (Pubitemid 19133351)
8. Leone A, Seeger RC, Hong CM, Hu YU, Arboleda MJ, Brodeuo GM, Stram D, Slamon DJ and Steeg PS: Somatic allelic deletion in nm23 in human cancer. Cancer Res 51: 2490-2493, 1991.
9. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge E, Liotta LA and Sobel ME: Evidence for a novel gene associated with low tumour metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
10. Hennessey C, Henry JA, May FEB, Wesley BR, Angus B and Lennard TWJ: Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 83: 281-285, 1991.
11. Leone A, Flatow U, King CR, Sandeen MA, Margulies IMK, Liotta LA and Steeg PS: Reduced tumour incidence, metastatic potential, and cytokine responsive of nm23 transfected melanoma cells. Cells 65: 25-35, 1991. (Pubitemid 121001210)
12. Lacombe ML, Milon L, Mehus JG and Lambeth DO: The human nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32: 247-258, 2000.
13. Ohneda K, Fukuda M, Shimada N, Ishikawa N, Ichou T, Kaji K, Toyota T and Kimura N: Increased expression of nucleoside diphosphate kinases/nm23 in human diploid fibroblasts transformed by SV40 large T antigen or 60Co irradiation. FEBS Lett 348: 273-277, 1994.
14. Keim D, Hailat N, Melhem R, Zhu XX, Lascu I, Veron M, Strahler J and Hanash SM: Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest 89: 919-924, 1992.
15. Wallet V, Mutzel R, Troll H, Barzu O, Wurster B, Veron M and Lacombe ML: Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development. J Natl Cancer Inst 82: 1199-1202, 1990. (Pubitemid 20219495)
16. Freije JM, Lawrence JA, Hollingshead MG, De la Rosa A, Narayanan V, Grever M, Sausville EA, Paull K and Steeg PS: Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines. Nat Med 3: 395-401, 1997. (Pubitemid 27145680)
17. Ma D, Xing Z, Liu B, Pedigo NG, Zimmer SG, Bai Z, Postel EH and Kaetzel DM: NM23-H1 and NM23-H2 repress transcriptional activities of nuclease-hypersensitive elements in the platelet-derived growth factor-A promoter. J Biol Chem 277: 1560-1567, 2002. (Pubitemid 34968914)
18. Mao H, Liu H, Fang Z, Abrams J and Worsham MJ: Loss of nm23 expression predicts distal metastases and poorer survival for breast cancer. Int J Oncol 18: 587-591, 2001.
19. Ravaroula P, Kourounis G, Ladopoulos I and Tzigounis V: Immunohistochemical analysis of nm3-H1 expression in human cervical lesions. Eur J Gynaecol Oncol 21: 510-512, 2000. (Pubitemid 32095004)
20. Viel A, Dall'Agnese L, Canzonieri V, Sopracordevole F, Capozzi E, Carbone A, Visentin MC and Baiocchi M: Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastases. Cancer Res 55: 2645-2650, 1995.
21. Nakayama T, Ohtsuru A, Nakao K, Shima M, Nakata K, Watanabe K, Ishii N, Kimura N and Nagataki S: Expression in human hepatocellular carcinoma of nucleoside diphospate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst 84: 1349-1354, 1992.
22. Nakayama H, Yasui W, Yokozaki H and Tahara E: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 84: 184-190, 1993. (Pubitemid 23099455)
23. Zafon C, Obiols G, Castellvi J, Tallada N, Galofre P, Gemar E, Mesa J and Simo R: Nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma. J Clin Endocrinol Metab 86: 3975-3980, 2001. (Pubitemid 32756007)
24. Colin KH, Wang FS, Desoto La Paix F, Solomon WB, Patterson LG, et al: Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet 338: 722-724, 1991.
25. Wang L, Patel U, Ghosh L, Chen HC and Banerjee S: Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res 53: 717-720, 1993. (Pubitemid 23077848)
26. Yamaguchi A, Urano T, Fushida S, Furukawa K, Nishimura G, Yonemura Y, Miyazaki I, Nakagawara G and Shiku H: Inverse association of nm23-HI expression by colorectal cancer with liver metastasis. Br J Cancer 68: 1020-1024, 1993. (Pubitemid 23315242)
27. Martinez JA, Prevot S, Nordlinger B, Nguyen TM, Lacarriere Y, Munier A, Lascu I, Vaillant TC, Capeau J and Lacombe ML: Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 37: 712-720, 1995.
28. Tannapfel A, Kockerling F, Katalinic A and Wittekind C: Expression of nm23-Hl predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum 38: 651-654, 1995.
29. Sards M and Lee CS: Nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver. Eur J Surg Oncol 27: 170-174, 2001.
30. Lee JC, Lin YJ, Chow NH and Wang ST: Reappraisal of the role of NM23-HI in colorectal cancers. J Surg Oncol 76: 58-62, 2001.
31. Tabuchi Y, Nakamura T, Kuniyasu T, Ohno M and Nakae S: Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival. Surg Today 29: 116-120, 1999. (Pubitemid 29088857)
32. Heys SD, Langlois N, Smith IC, Walker LG and Eremin O: NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer. Oncol Rep 5: 735-739, 1998. (Pubitemid 28189339)
33. Lindmark G: NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. Br J Cancer 74: 1413-1418, 1996.
34. Gunther K, Dworak O, Remke S, Pfluger R, Merkel S, Hohenberger W and Reymond MA: Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 103: 68-78, 2002. (Pubitemid 34953394)
35. Crowe PJ, Yang JL, Berney CR, Erskine C, Ham JM, Fisher R and Russell PJ: Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer. World J Surg 25: 996-1001, 2001. (Pubitemid 32747646)
36. Indinnimeo M, Giarnieri E, Stazi A, Cicchini C, Brozzetti S, Valli C, Carreca I and Secchione A: Early stage human colorectal cancer: prognostic value of nm23-H1 protein overexpression. Cancer Lett 111: 1-5, 1997. (Pubitemid 27068211)
37. Dupont WD and Plummer WD: PS power and sample size program available for free on the Internet. Control Clin Trials 18: 274-279, 1997.
38. Iraka R and Gentleman RR: A language for data analysis and graphics. J Comput Graphic Statists 5: 299-314, 1996.
39. MacDonald NJ, De la Rosa A, Benedict MA, Freije JM, Krutsch H and Steeg PS: A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 268: 25780-25789, 1993. (Pubitemid 23358195)
40. Zeng ZS, Hsu S, Zhang ZF, Cohen AM, Enker WE, Turnbull AA and Guillem JG: High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer 70: 1025-1030, 1994. (Pubitemid 24331108)
41. Cheah PY, Cao X, Eu KW and Seow-Choen F: NM23-H1 immunostaining is inversely associated with tumor staging but not overall survival or disease recurrence in colorectal carcinomas, Br J Cancer 77: 1164-1168, 1998. (Pubitemid 28116291)
42. Haut M, Steeg PS, Willson JK and Markowitz SD: Induction of nm23 gene expression in human colonic neoplasm and equal expression in colon tumor of high and low metastatic potential. J Natl Cancer Inst 83: 712-716, 1991.
43. Dursun A, Akyurek N, Gunel N and Yamac D: Prognostic implication of nm23-H1 expression in colorectal carcinomas. Pathology 34: 427-432, 2002. (Pubitemid 35205244)
44. Katakura H, Tanaka F, Oyanagi H, Miyahara R, Yanagihara K, Otake Y and Wada H: Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer. Ann Thorac Surg 73: 1060-1064, 2002. (Pubitemid 34275878)
45. Campo E, Miquel R, Jares P, Bosch F, Juan M, Leone A, et al: Prognostic significance of the loss of heterozigosity of nm23-H1 and p53 genes in human colorectal carcinomas. Cancer 73: 2913-2921, 1994. (Pubitemid 24170763)
46. Langlois N, Walker LG, Smith I, Skinner L, Eremin O and Heys SD: Expression of growth factor receptors in not a prognostic indicator in young patients with colorectal cancer. J Roy Coll Surg 42: 98-101, 1997. (Pubitemid 27170642)